Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Report from the Extraordinary General Meeting 2021 in Elekta

SWEDEN, April 16, 2021 – Elekta AB (publ) (EKTA-B.ST) has held an Extraordinary General Meeting on Friday 16 April 2021. Due to Covid-19, the Meeting was conducted by advance postal vote, without the physical attendance of shareholders, representatives or third parties.A summary of the resolutions taken by the Meeting follows. For complete details concerning all resolutions, please see the Meeting documents that are available on the Company’s website, www.elekta.com. Extra dividend and record dateThe Meeting resolved, in accordance with the Board of Directors’ proposal, on an extra

Vator Securities: Unlocking US reimbursement – the share price catalyst during 2021

SciBase is delivering as we expected, and the share price is closing in on our target price. Recent news flow confirms the Nevisense EIS-technology’s potential for skin barrier assessment applications – an upside to both our and the market’s valuation of the company. The apparent tangible driver of the share price for the coming 12 months, however, is unlocking US reimbursement (Medicare) where the US company DermTech offers a clear blueprint. DermTech (DMTK: Nasdaq US) is a close peer to SciBase, commercializing a molecular assay for melanoma detection in the US. DermTech generated

Dignitana publishes April newsletter

Dignitana AB today publishes the April newsletter featuring the recent Dignitana presentation at the Life Science Capital Markets Days and a DigniCap patient video. To read the newsletter click here  or visit Dignitana.com .The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.se as part of Dignitana's commitment to provide ongoing communication to the market. To receive future Dignitana news directly to your email, subscribe here 

Cereno Scientific sets study timeline of upcoming Phase II study with CS1 in rare disease PAH to start September 2021

Cereno Scientific today announced that the timelines for the upcoming clinical Phase II with drug candidate CS1 has been set following the signing of the final agreements with clinical research organization Worldwide Clinical Trials. The preparatory work together with Worldwide has proceeded since a letter of intent (LOI) was signed earlier this year, resulting in a study timeline for the Phase II study with CS1 in PAH anchored with relevant parties. If the study timeline is followed according to plan, the first patient will start in September 2021 with study results expected in H2 2022.“

Invitation to AAK’s presentation of the first quarter 2021 on April 23

In connection with the release of AAK’s Interim report for the first quarter 2021, we invite you to a press and analyst conference to be held on Friday, April 23, 2021, at 1 p.m. CET. The conference will be chaired by Johan Westman, President and CEO, and the presentation will be held in English. The presentation can be followed by phone or via a webcast. Please note that questions may be asked by phone only. To follow the conference by phone, please use one of the following numbers:SE: +46 8 566 426 95DK: +45 7872 3250UK: +44 3333 009 263US: +1 833 249 8403 To follow the

Talkpool AG invites its shareholders to attend the Annual General Meeting

Invitation to the Annual General Meeting of Talkpool AG on the 6[th] of May 2021Talkpool AG invites its shareholders to remotely attend the Annual General Meeting via video on the 6[th] of May 2021 at 10:00. The meeting will be streamed from Talkpool’s offices at Gäuggelistrasse 7, 7000 Chur, Switzerland. Shareholders should beforehand instruct the independent representative about voting preferences.This is a summary. The full invitation and registration document is available from the 16[th] of April 2021 on Talkpool’s website https://talkpool.com/financial-calendar/#investor

EQL chooses to postpone the list change to Nasdaq Stockholm

EQL Pharma revises the schedule for the planned list change from Spotlight Stock Market to Nasdaq Stockholm's main list, with the goal that the list change will be carried out after the summer of 2021 instead of the first quarter of the financial year 2021/22 as previously communicated.The decision to postpone the list change is due to the prioritization of the acquisition of seven product licenses in Denmark during the spring and winter, which was announced on March 15, 2021. Through that prioritization, the company needed to move resources from the listing process to the acquisition. This

New analysis shows significant long-term potential in Brighter’s various offers and the company’s share price

Brighter AB [publ],  today announced that Aktiespararna has provided an updated company analysis.  Included in Aktiespararna’s update is an analysis of the key milestones that Brighter has completed across the company’s three product lines: Actiste®, Camanio and Nectarine Health.  Brighter signed distribution agreements in three new markets: Ghana, Nigeria and Qatar for Actiste and received market approvals for Actiste® and Actiste® Mini in various regions. The analysis continues to discuss the establishment of a framework agreement with Sweden's Municipalities and Regions for Camanio

Two recently published papers mark a milestone for Attana which now has enabled 140 scientific publications

Two new scientific publications featuring Attana’s analytical instruments have recently been published in peer reviewed journals including the highly regarded Sensors and Actuators B: Chemical as well as Plos One. The two new publications mark a milestone for Attana, which has to date enabled 140 publications.Publication 1: Direct Attachment of suspension cells to PDA surface and its application in suspension-cell QCM biosensor The study investigated the attachment property of suspension cells on the Mussel-inspired polydopamine (PDA) surface. The study was based upon a PDA-based

Notice of annual general meeting in Nordic Paper Holding AB (publ)

The shareholders of Nordic Paper Holding AB (publ), Reg. No. 556914-1913, with its registered office in Karlstad municipality in Värmland county, (the “Company” or “Nordic Paper”), are hereby invited to the annual general meeting on Thursday 20 May 2021.Due to the extraordinary situation resulting from the covid-19 pandemic, Nordic Paper’s annual general meeting will be carried out through mandatory advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the annual general

BioStock: Respiratorius sees great potential for new COPD treatment

Chronic obstructive pulmonary disease is today one of the most common causes of death globally. Although the market for treatments for the disease is vast, it is largely based on medicines with old modes of action. This is something that Lund-based Respiratorius wants to change with its RESP9000 project, which aims to develop an effective tool in the fight against the disease. The company sees several value-creating milestones on its way to clinical testing.Read the full article at biostock.se: https://www.biostock.se/en/respiratorius-sees-great-potential-for-new-copd-treatment/This is

Nexam Chemical publishes Annual Report for 2020

Nexam Chemical Holding AB (publ) announce that a Swedish version of the Annual Report for 2020 is now available on the company´s website www.nexamchemical.com. Note: This news has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.For more information, please contact: Johan Arvidsson, CEO, +46-708 97 44 39, johan.arvidsson@nexamchemical.com

Notice of Annual General Meeting in Dignitana AB (Publ)

The shareholders of Dignitana AB (publ) reg. no. 556730-5346 (“Dignitana” or the “Company”) are hereby given notice of the Annual General Meeting (the “AGM”) to be held on 20 May 2021.NOTE: This is an unofficial translation of the original Swedish notice. In case of discrepancies, the Swedish version shall prevail.   The shareholders of Dignitana AB (publ) reg. no. 556730-5346 (“Dignitana” or the “Company”) are hereby given notice of the Annual General Meeting (the “AGM”) to be held on 20 May 2021. Dignitana welcomes all shareholders to exercise their voting rights for the AGM

Diös is hosting a presentation of Interim Report Jan-Mar 2021

Diös Fastigheter Interim Report for Jan-Mar 2021 will be published at 07:00 am (CEST) on 23 April 2021. The same day, at 09:00 am, investors, analyst, media and other stakeholders are invited to participate in the online audiocast with teleconference.[Emma Widegren] CEO Knut Rost and CFO Rolf Larsson will present the result for the period. The presentation will be held in English and will conclude with a Q&A session. Date:              April 23, 2021Time:             The presentation begins at 09:00 (CEST)To participate in the teleconference, please dial in on any of the numbers

NENT Group launches Börje Salming biopic as latest original series

· Hockey Hall of Famer Börje Salming is one of Sweden’s greatest-ever ice hockey stars and played 1,100+ NHL games · English-language series created and directed by Amir Chamdin (the Canneseries 2020 winner ‘Partisan’) and stars Valter Skarsgård (‘Arn’) · NENT Group to premiere at least 40 original productions in 2021 The dramatic career of Börje Salming, one of Sweden’s greatest-ever ice hockey players, is the subject of the next Viaplay Original from Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company. Valter Skarsgård (‘Arn’) takes on the title

Publishing of YIT Corporation's Interim report 1-3/2021 on 30 April 2021

YIT Corporation  Investor News  16 April 2021 at 10.00 a.m.YIT Corporation's Interim report for the first quarter of 2021 will be published on Friday, 30 April 2021 at approximately 9.00 a.m. Finnish time (EET, approx. 7.00 a.m. GMT). The stock exchange release and the reporting materials in Finnish and in English will be published at that time on the company's website at www.yitgroup.com/investors. News conference for investors and media YIT will arrange a news conference on Friday, 30 April 2021 at 10.00 a.m. Finnish time (EET, at 8.00 a.m. GMT). The results will be presented by

Notice of Annual General Meeting in Paradox Interactive AB (publ) on 18 May 2021

Paradox Interactive AB (publ) has summoned the shareholders to the Annual General Meeting on 18 May 2021 (the “AGM”). Due to Covid-19, the board of directors have decided that the AGM shall be carried out through advance voting (postal voting) only and without physical attendance of shareholders, proxies or persons who are not shareholders. The company invites the shareholders to exercise their voting rights at the AGM by way of advance voting in accordance with the below instructions. Information on the resolutions passed at the AGM will be made public on Tuesday 18 May 2021 as soon as

First servers for data centers certified for sustainability

Like other IT products, data center products come with social and environmental challenges. With Hewlett Packard Enterprise taking the lead, the first servers are now certified according to the rigorous sustainability criteria in TCO Certified.TCO Certified  is the global leading sustainability certification for IT products. With environmental and social criteria, TCO Certified covers the full lifecycle of the product, including supply chain responsibility, hazardous substances, and circular criteria promoting. This life-cycle approach results in more circular

Smoltek extends license agreement for technical and commercial evaluation of its CNF-MIM capacitor technology

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek announces that the license agreement, signed with a global manufacturer of electronic components for its technical and commercial evaluation of Smoltek’s capacitor technology, will be further extended until the end of August 2021. The extended joint project will continue with the aim of making it possible for the customer to enter into a commercial licensing agreement with Smoltek.The license agreement signed in April 2020 with a world-leading manufacturer of

Minesto enhances and extends its IP protection with approved patent

Leading marine energy developer Minesto reinforces its already extensive patent portfolio covering the company’s unique ocean energy technology. Minesto has been granted a new patent by which the company extends the protection of its core technology.The approved patent concerns a technical innovation that Minesto developed and has verified in its tidal energy project in the Faroe Islands. Among other things, the solution provides greater flexibility as to which sea depths Minesto's tidal kite systems can be installed at.     “We continue to strengthen and extend the protection of our

Medivir appoints Magnus Christensen as interim CEO

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announced today that its Board of Directors appoints Magnus Christensen, the company’s CFO, as interim CEO of Medivir. Magnus has been CFO of the company since 2019 and will take up his new role in connection with Medivir's Annual General Meeting on May 5, 2021. Magnus will in parallel retain his role as CFO.As previously communicated, Yilmaz Mahshid will leave his position as CEO at the Annual General Meeting (AGM) 2021. Medivir’s nomination committe proposes that Yilmaz Mahshid is elected new board member at the AGM. The Board has

New Wave Group’s profit for the first quarter substantially exceeds market expectations

The interim report for New Wave Group will be presented on 27 April, but as New Wave Group expects to report a profit for the first quarter 2021 which substantially exceeds both previous year and market expectations based on analysts’ estimates, preliminary numbers are released for the quarter. Operating result for the first quarter 2021 increased by SEK 124 million to SEK 100 (-24) million. Net result increased by SEK 105 million to SEK 68 (-37) million. Sales amounted to SEK 1,262 (1,441) million, which is a decrease of 12% (7% in local currencies). The full interim report for the

There are no items matching the current filter
There are no more items matching the current filter
Back to top